23.73 (CH2), 25.63 (CH3), 39.54 (CH2), 48.56 (C), 63.25 (CH2),
84.37 (CH), 92.09 (C), 124.82 (CH), 125.56 (CH), 126.18 (CH),
126.60 (CH), 126.85 (CH), 128.05 (CH), 128.29 (CH), 131.24 (C),
144.20 (C), 145.47 (C); EI-MS (M+): Calcd for C23H28O2, 336.2089;
Found, 336.2097; IR (neat, cm-1): 3434, 3058, 2968, 2929, 2870,
1737, 1448, 990, 709.
7.56–7.61 (m, 2H); 13C NMR (125 MHz, CDCl3): d 16.50 (CH3),
21.19 (CH3), 26.12 (CH3), 29.95 (CH2), 34.91 (CH2), 45.51 (C),
57.84 (CH3), 68.94 (CH2), 85.11 (CH), 90.44 (C), 120.98 (CH),
125.06 (CH), 125.61 (CH), 126.22 (CH), 126.36 (CH), 127.62
(CH), 127.90 (CH), 139.82 (C), 144.34 (C), 145.22 (C); ESI-MS
([M+Na]+): Calcd for C24H30O2Na, 373.2138; Found, 373.2144;
IR (neat, cm-1): 3058, 2957, 2932, 2871, 1673, 1448, 1103, 996,
709.
(E)-5-(3,3-Dimethyl-4,4-diphenyloxetan-2-yl)-3-methylpent-2-
en-1-ol (3a). 1H NMR (500 MHz, C6D6): d 0.95 (s, 3H), 0,99 (s,
3H), 1.43–1.53 (m, 1H), 1.49 (s, 3H), 1.73–1.85 (m, 1H), 1.88–1.98
(m, 1H), 2.15–2.25 (m, 1H), 3.99–4.05 (m, 2H), 4.29 (dd, J = 4.29
and 8.76 Hz, 1H), 5.42–5.49 (m, 1H), 6.98–7.08 (m, 2H), 7.12–
7.25 (m, 4H), 7.53–7.58 (m, 2H), 7.68–7.73 (m, 2H); 13C NMR
(125 MHz, C6D6): d 16.18 (CH3), 21.28 (CH3), 26.08 (CH3), 30.28
(CH2), 35.21 (CH2), 45.59 (C), 59.29 (CH2), 85.23 (CH), 90.73
(C), 125.06 (CH), 125.49 (CH), 126.06 (CH), 126.53 (CH), 126.70
(CH), 127.95 (CH), 128.26 (CH), 137.74 (C), 144.97 (C), 145.88
(C); EI-MS (M+): Calcd for C23H28O2, 336.2089; Found, 336.2084;
IR (neat, cm-1): 3400, 3057, 2959, 2934, 2870, 1669, 1447, 996, 709.
(E)-3,7-Dimethylocta-2,6-dien-1-yl acetate (1c). In a flame-
dried 50 mL two-neck round bottom flask, equipped with
magnetic stir bar, were placed geraniol 1a (3.0 mL, 17.29 mmol),
triethylamine (2.7 mL, 19 mmol) and dry CH2Cl2 (15 mL)
via syringe. The flask was cooled in an ice bath and acetic
anhydride (1.8 mL, 19 mmol) was added dropwise via syringe.
The resulting solution was stirred under a stream of nitrogen at
room temperature overnight. The reaction mixture was washed
with H2O (20 mL), NaHCO3 (2 ¥ 20 mL) and H2O (20 mL) and the
aqueous extracts were back-extracted with CH2Cl2 (20 mL). The
combined organic layer was washed with brine, dried over Na2SO4,
and concentrated. The residue was purified by flash column
chromatography (hexane–EtOAc = 9 : 1 v/v) to give colorless oil
(2.96 g, 15.07 mmol, yield = 87%). 1H NMR (CDCl3, 500 MHz):
d1.60 (s, 3H), 1.68 (s, 3H), 1.70 (s, 3H), 2.01–2.14 (m, 7H), 4.58 (d,
J = 7.08 Hz, 2H), 5.05–5.10 (m, 1H), 5.31–5.36 (m, 1H); APCI-MS
([M+H]+): Calcd for C12H21O2, 197.1536; Found, 197.1533.
(E)-1-Methoxy-3,7-dimethylocta-2,6-diene (1b). NaH (0.35 g,
8.65 mmol) was washed with hexane. The washed NaH was
dissolved in dry THF (10 ml). To this solution, geraniol 1a (1.00 g,
6.50 mmol) in dry THF (10 ml) was added dropwise. The reaction
◦
mixture was stirred 1 h at 0 C. After the addition, MeI (1.41 g,
9.90 mmol) in dry THF (10 ml) was added to the reaction mixture
at rt. After the addition, the reaction mixture was stirred over
night. The reaction mixture was quenched by the addition of water
and extracted with ether. The combined organic layer was washed
with brine, dried over MgSO4, and concentrated. The residue was
purified by flash column chromatography (hexane–EtOAc = 9 : 1
v/v) to give yellow oil (0.95 g, 5.65 mmol, yield = 87%). 1H NMR
(500 MHz, CDCl3): d 1.60 (s, 3H), 1.68 (s, 6H), 2.02–2.07 (m, 2H),
2.08–2.14 (m, 2H), 3.32 (s, 3H), 3.93 (d, J = 6.78 Hz, 2H), 5.07–
5.13 (m, 1H), 5.32–5.37 (m, 1H); 13C NMR (125 MHz, CDCl3): d
16.39 (CH3), 17.63 (CH3), 25.64 (CH3), 26.38 (CH2), 39.57 (CH2),
57.70 (CH3), 68.94 (CH2), 120.72 (CH), 123.97 (CH), 131.60 (C),
140.31 (C); APCI-MS ([M+H]+): Calcd for C11H21O, 169.1587;
Found, 169.1586.
((2S,3R)-3-Methyl-3-(4-methylpent-3-en-1-yl)-4,4-diphenyloxe-
1
tan-2-yl)methyl acetate (2c). 1H NMR (500 MHz, CDCl3): H
NMR (500 MHz, CDCl3): d 1.11 (s, 3H), 1.36–1.49 (m, 2H), 1.53
(s, 3H), 1.62 (s, 3H), 1.71–1.81 (m, 1H), 1.88–1.98 (m, 1H), 2.10 (s,
3H), 4.20–4.24 (m, 2H), 4.64 (dd, J 5.27 and 6.42 Hz, 1H), 4.88–
4.93 (m, 1H), 7.16–7.23 (m, 2H), 7.28–7.36 (m, 4H), 7.41–7.47 (m,
2H), 7.55–7.62 (m, 2H); 13C NMR (125 MHz, CDCl3): d 17.61
(CH3), 17.89 (CH3), 20.95 (CH3), 23.26 (CH2), 25.59 (CH3), 38.84
(CH2), 48.60 (C), 65.12 (CH2), 81.28 (CH), 92.32 (C), 123.86 (CH),
125.16 (CH), 125.75 (CH), 126.51 (CH), 126.70 (CH), 127.76
(CH), 128.06 (CH), 131.83 (C), 143.20 (C), 144.35 (C), 170.85
(C); ESI-MS ([M+Na]+): Calcd for C25H30O3Na, 401.2087; Found,
401.2089; IR (neat, cm-1): 3058, 2969, 2931, 2881, 1744, 1448, 1234,
995, 709.
(3R,4S)-4-(Methoxymethyl)-3-methyl-3-(4-methylpent-3-en-1-
yl)-2,2-diphenyloxetane (2b). 1H NMR (500 MHz, CDCl3): d
1.09 (s, 3H), 1.34–1.48 (m, 2H), 1.53 (s, 3H), 1.62 (s, 3H), 1.71–
1.81 (m, 1H), 1.87–1.97 (m, 1H), 3.41 (s, 3H), 3.45–3.49 (m, 1H),
3.58–3.63 (m, 1H), 4.63 (dd, J = 4.26 and 7.39 Hz, 1H), 4.90–4.95
(m, 1H), 7.15–7.21 (m, 2H), 7.27–7.34 (m, 4H), 7.42–7.47 (m, 2H),
7.57–7.62 (m, 2H); 13C NMR (125 MHz, CDCl3): d 17.58 (CH3),
17.75 (CH3), 23.32 (CH2), 25.63 (CH3), 38.86 (CH2), 48.51 (C),
59.34 (CH3), 73.77 (CH2), 82.46 (CH), 92.06 (C), 124.12 (CH),
125.23 (CH), 125.84 (CH), 126.35 (CH), 126.54 (CH), 127.66
(CH), 127.99 (CH), 131.57 (C), 143.46 (C), 144.80 (C); ESI-MS
([M+Na]+): Calcd for C24H30O2Na, 373.2138; Found, 373.2140;
IR (neat, cm-1): 3058, 2957, 2932, 2871, 1673, 1448, 1103, 996,
709.
(E)-5-(3,3-Dimethyl-4,4-diphenyloxetan-2-yl)-3-methylpent-2-
en-1-yl acetate (3c). 1H NMR (500 MHz, CDCl3): d 1.05 (s, 3H),
1.07 (s, 3H), 1.57–1.66 (m, 1H), 1.73 (s, 3H), 1.75–1.84 (m, 1H),
2.00–2.08 (m, 1H), 2.04 (s, 3H), 2.20–2.29 (m, 1H), 4.30 (dd, J =
4.87 and 8.53 Hz, 1H), 4.59 (d, J = 7.01 Hz, 2H), 5.37–5.42 (m,
1H), 7.14–7.20 (m, 2H), 7.26–7.33 (m, 4H), 7.43–7.47 (m, 2H),
7.56–7.60 (m, 2H); 13C NMR (125 MHz, CDCl3): d 16.49 (CH3),
21.02 (CH3), 21.22 (CH3), 26.07 (CH3), 29.78 (CH2), 34.92 (CH2),
45.52 (C), 61.30 (CH2), 85.00 (CH), 90.47 (C), 1118.58 (CH),
125.05 (CH), 125.60 (CH), 126.25 (CH), 126.39 (CH), 127.62
(CH), 127.92 (CH), 141.72 (C), 144.30 (C), 145.21 (C), 171.05
(C); ESI-MS ([M+Na]+): Calcd for C25H30O3Na, 401.2087; Found,
401.2085; IR (neat, cm-1): 3058, 2956, 2870, 1738, 1448, 1233, 996,
710.
(E)-4-(5-Methoxy-3-methylpent-3-en-1-yl)-3,3-dimethyl-2,2-
diphenyloxetane (3b). 1H NMR (500 MHz, CDCl3): d 1.05 (s,
3H), 1.06 (s, 3H), 1.58–1.68 (m, 1H), 1.70 (s, 3H), 1.75–1.85 (m,
1H), 1.98–2.06 (m, 1H), 2.19–2.28 (m, 1H), 3.32 (s, 3H), 3.94 (d,
J 6.70 Hz, 2H), 4.31 (dd, J = 5.41 and 8.38 Hz, 1H), 5.37–5.41
(m, 1H), 7.13–7.20 (m, 2H), 7.25–7.34 (m, 4H), 7.43–7.48 (m, 2H),
Determination of quantum yields of oxetane formation
The quantum yields of the oxetane formations from the pho-
toreaction of benzophenone with 1a were measured by xenon
1472 | Photochem. Photobiol. Sci., 2011, 10, 1469–1473 This journal is
The Royal Society of Chemistry and Owner Societies 2011
©